Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO)
INR 39.36
(-0.58%)
INR 39.36
(-0.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 436.8 Million INR | -57.06% |
| 2022 | 63.91 Million INR | -70.13% |
| 2021 | 213.94 Million INR | 3704.09% |
| 2020 | 5.62 Million INR | 111.96% |
| 2019 | -47 Million INR | -248.59% |
| 2018 | 31.63 Million INR | 121.8% |
| 2017 | -145.12 Million INR | 2.73% |
| 2016 | -149.19 Million INR | -124.16% |
| 2015 | 617.41 Million INR | 1131.82% |
| 2014 | -59.83 Million INR | 69.39% |
| 2013 | -195.47 Million INR | -18.49% |
| 2012 | -164.97 Million INR | 0.0% |
| 2009 | 48.06 Million INR | -72.07% |
| 2008 | 172.09 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.44 Million INR | 87.43% |
| 2023 Q2 | -841 Thousand INR | 97.92% |
| 2023 Q3 | 13.96 Million INR | 1759.93% |
| 2023 Q4 | 54.75 Million INR | 292.26% |
| 2023 FY | 27.44 Million INR | -57.06% |
| 2023 Q1 | -40.43 Million INR | -266.39% |
| 2022 Q2 | 7.21 Million INR | -47.71% |
| 2022 FY | 63.91 Million INR | -70.13% |
| 2022 Q1 | 13.8 Million INR | 81.59% |
| 2022 Q3 | 12.82 Million INR | 77.64% |
| 2022 Q4 | 24.29 Million INR | 89.51% |
| 2021 Q4 | 7.6 Million INR | -86.82% |
| 2021 Q3 | 57.67 Million INR | -38.13% |
| 2021 FY | 213.94 Million INR | 3704.09% |
| 2021 Q2 | 93.21 Million INR | 38.67% |
| 2021 Q1 | 67.22 Million INR | 205.43% |
| 2020 Q4 | -63.75 Million INR | -256.78% |
| 2020 FY | 5.62 Million INR | 111.96% |
| 2020 Q3 | 40.66 Million INR | -67.62% |
| 2020 Q2 | 125.6 Million INR | 484.65% |
| 2020 Q1 | 21.48 Million INR | -85.23% |
| 2019 Q1 | 14.76 Million INR | -68.18% |
| 2019 FY | -47 Million INR | -248.59% |
| 2019 Q3 | 9.46 Million INR | -2.08% |
| 2019 Q4 | 145.48 Million INR | 1436.62% |
| 2019 Q2 | 9.66 Million INR | -34.5% |
| 2018 Q3 | 39.08 Million INR | 105.97% |
| 2018 Q2 | 18.97 Million INR | 33.52% |
| 2018 Q1 | 14.21 Million INR | 136.86% |
| 2018 Q4 | 46.39 Million INR | 18.7% |
| 2018 FY | 31.63 Million INR | 121.8% |
| 2017 FY | -145.12 Million INR | 2.73% |
| 2017 Q4 | -38.55 Million INR | -201.36% |
| 2017 Q3 | 38.04 Million INR | 281.99% |
| 2017 Q2 | -20.9 Million INR | -125.57% |
| 2017 Q1 | -9.26 Million INR | 0.0% |
| 2016 FY | -149.19 Million INR | -124.16% |
| 2015 FY | 617.41 Million INR | 1131.82% |
| 2014 FY | -59.83 Million INR | 69.39% |
| 2013 FY | -195.47 Million INR | -18.49% |
| 2012 FY | -164.97 Million INR | 0.0% |
| 2009 FY | 48.06 Million INR | -72.07% |
| 2008 FY | 172.09 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sunil Healthcare Limited | -19.98 Million INR | 2286.112% |
| ANG Lifesciences India Limited | 12.8 Million INR | -3311.222% |
| BDH Industries Limited | 169.01 Million INR | -158.441% |
| Deccan Health Care Limited | 185.32 Million INR | -135.693% |
| DECIPHER LABS LIMITED | 53.74 Million INR | -712.815% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 48.85% |
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -82037.458% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -5382.016% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 34.712% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 1256.89% |
| MedPlus Health Services Limited | 1.31 Billion INR | 66.901% |
| Patidar Buildcon Limited | -1.83 Million INR | 23891.231% |
| Add-Shop E-Retail Limited | 77.57 Million INR | -463.106% |
| Bacil Pharma Limited | -1.89 Million INR | 23158.532% |
| Beryl Drugs Limited | 14.73 Million INR | -2865.022% |
| Cian Healthcare Limited | 53.96 Million INR | -709.366% |
| Concord Drugs Limited | 24.87 Million INR | -1656.22% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | -577.527% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | -4758.81% |
| Sastasundar Ventures Limited | -229.64 Million INR | 290.207% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 107687.931% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | -1178.896% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | -102.527% |
| Syschem (India) Limited | 504.91 Million INR | 13.489% |
| Medi-Caps Limited | -17.21 Million INR | 2638.1% |
| Parmax Pharma Limited | 3.75 Million INR | -11534.071% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Phaarmasia Limited | - INR | -Infinity% |
| Transchem Limited | -17.43 Million INR | 2604.771% |
| Trinity League India Limited | 1.17 Million INR | -37138.448% |
| Tyche Industries Limited | 111.22 Million INR | -292.731% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 4404.79% |
| Zenith Healthcare Limited | 196 Thousand INR | -222760.714% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | -2557.785% |
| Colinz Laboratories Limited | 14.64 Million INR | -2883.043% |
| Denis Chem Lab Limited | 142.87 Million INR | -205.722% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 12.762% |
| Makers Laboratories Limited | -34.91 Million INR | 1351.237% |
| Panchsheel Organics Limited | 288.28 Million INR | -51.517% |
| Parnax Lab Limited | 166.84 Million INR | -161.806% |
| PRAVEG LIMITED | 185.06 Million INR | -136.024% |
| Mercury Laboratories Limited | 62.14 Million INR | -602.85% |
| Trident Lifeline Limited | 72.21 Million INR | -504.904% |
| Vikram Thermo (India) Limited | 339.45 Million INR | -28.678% |
| Vivanza Biosciences Limited | 14.83 Million INR | -2845.031% |
| Zenlabs Ethica Limited | 89.27 Million INR | -389.272% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | -342.693% |
| Vasundhara Rasayans Limited | 61.27 Million INR | -612.852% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 372.878% |
| Roopa Industries Limited | 48.05 Million INR | -808.935% |
| PANJON LTD. | - INR | -Infinity% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 392.546% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 2537.947% |
| Anuh Pharma Limited | 682.19 Million INR | 35.971% |
| Crestchem Limited | 27.25 Million INR | -1502.615% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 3815.925% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | -2450.698% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | -19.918% |
| Trimurthi Limited | -6.14 Million INR | 7210.6% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | -84.883% |
| Norris Medicines Limited | 11.15 Million INR | -3815.035% |
| Veerhealth Care Limited | 34.19 Million INR | -1177.512% |
| Lactose (India) Limited | 137.78 Million INR | -217.018% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 453.484% |
| Gennex Laboratories Limited | 146.61 Million INR | -197.922% |
| Godavari Drugs Limited | -67.67 Million INR | 745.487% |
| Zenotech Laboratories Limited | 242.37 Million INR | -80.219% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 23.7% |
| Bharat Parenterals Limited | 733.49 Million INR | 40.448% |
| Coral Laboratories Limited | 142.63 Million INR | -206.245% |
| Evoq Remedies Limited | 42.91 Million INR | -917.795% |
| Kerala Ayurveda Limited | 48.04 Million INR | -809.143% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 17713.185% |
| Natural Capsules Limited | 112.4 Million INR | -288.618% |
| Auro Laboratories Limited | 95.77 Million INR | -356.076% |